Current price is less than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

Returns vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

PAT stood at Rs108.9cr as compared to Rs100.1cr in H1 FY21, an increase of 8.8%.

Marksans Pharma’s net profit rises to Rs46.3cr in Q2FY22

Marksans Pharma Consolidated September 2021 Net Sales At Rs 361.20 Crore, Up 1.33% Y-o-Y

Bharat Heavy Electricals Ltd, Strides Pharma Science Ltd, Nirlon Ltd and Marksans Pharma Ltd are among the other losers in the BSE’s ‘A’ group today, 10 November 2021.

Firstsource Solutions Ltd leads losers in ‘A’ group

Marksans Pharma consolidated net profit declines 8.75% in the September 2021 quarter

Marksans Pharma standalone net profit rises 17.30% in the September 2021 quarter

Marksans Pharma jumped 3.29% to Rs 72.15 after the drug company received US drug regulator’s approval for acetaminophen extended-release tablets.

Marksans Pharma spurts after USFDA nod for acetaminophen

Acetaminophen Extended-Release Tablets are bioequivalent to the reference listed drug, Tylenol Extended-Release Tablets, 650 mg, of Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division.

Marksans Pharma receives USFDA approval for Acetaminophen ER Tablets

Marksans said that this product approval endorses the capability of Marksans to develop and deliver products on a high barrier platform technology of extended-release tablets.

USFDA approves Marksans Pharma’s Acetaminophen extended-release tablets; Stock ends 3% up

Marksans Pharma consolidated net profit rises 26.80% in the June 2021 quarter

Marksans Pharma Consolidated June 2021 Net Sales At Rs 348.96 Crore, Up 5.38% Y-o-Y

Here is a brief analysis of the Q1 earnings reported by some of the companies including Indoco Remedies, India Cements and Marksans Pharma.

#CNBCTV18 #BusinessNews #ShareMarketToday #Nifty #Sensex #Q1Analysis

CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.

For latest news and updates visit our Website: https://bit.ly/2YbpXBM
Subscribe to our Channel: https://www.youtube.com/user/CNBCTV18
Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News

Q1 Analysis: Indoco Remedies, India Cements, Marksans Pharma | Midcap Radar | CNBC-TV18

Marksans Pharma Limited is a pharmaceutical company, which is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations.

Marksans Pharma Ltd

Marksans Pharma Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Marksans Pharma’s net profit rises to Rs46.3cr in Q2FY22

Marksans Pharma Consolidated September 2021 Net Sales At Rs 361.20 Crore, Up 1.33% Y-o-Y

Firstsource Solutions Ltd leads losers in ‘A’ group

Marksans Pharma consolidated net profit declines 8.75% in the September 2021 quarter

Marksans Pharma standalone net profit rises 17.30% in the September 2021 quarter

Marksans Pharma spurts after USFDA nod for acetaminophen

Marksans Pharma receives USFDA approval for Acetaminophen ER Tablets

Marksans Pharma Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Marksans Pharma’s net profit rises to Rs46.3cr in Q2FY22

Marksans Pharma Consolidated September 2021 Net Sales At Rs 361.20 Crore, Up 1.33% Y-o-Y

Firstsource Solutions Ltd leads losers in ‘A’ group

Marksans Pharma consolidated net profit declines 8.75% in the September 2021 quarter

Marksans Pharma standalone net profit rises 17.30% in the September 2021 quarter

Marksans Pharma spurts after USFDA nod for acetaminophen

Marksans Pharma receives USFDA approval for Acetaminophen ER Tablets

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock